Skip to main content

Advertisement

SpringerLink
Log in

Response to Feuerstein J et al. “Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005–2013) for Barrett’s Esophagus”. doi:10.1007/s10620-016-4222-2

  • Correspondence
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bennett C, Vakil N, Bergman J, et al. Consensus statements for management of Barrett’s dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012;143:336–346.

    Article  PubMed  Google Scholar 

  2. Bennett C, Moayyedi P, Corley DA, et al. BOB CAT: a large-scale review and Delphi consensus for management of Barrett’s esophagus with no dysplasia, indefinite for, or low-grade dysplasia. Am J Gastroenterol. 2015;110:662–682 (quiz 683).

    Article  PubMed  PubMed Central  Google Scholar 

  3. National Institute for Health and Clinical Excellence (NICE). Final Accreditation Report: Consensus Statements for Management of Barrett’s Dysplasia and Early-Stage Oesophageal Adenocarcinoma. 2012. https://www.nice.org.uk/Media/Default/About/accreditation/accreditation-decisions/BAD-CAT-consensus-group-final-decision.pdf. Accessed July 5, 2016.

  4. Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–394.

    Article  PubMed  Google Scholar 

  5. Das D, Chilton AP, Jankowski JA. Chemoprevention of oesophageal cancer and the AspECT trial. Recent Results Cancer Res. 2009;181:161–169.

    Article  CAS  PubMed  Google Scholar 

  6. Old O, Moayyedi P, Love S, et al. Barrett’s oesophagus surveillance versus endoscopy at need study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial. J Med Screen. 2015;22:158–164.

    Article  PubMed  Google Scholar 

  7. Bennett C, Moayyedi P, Corley DA, et al. Addendum: BOB CAT: a large-scale review and Delphi consensus for management of Barrett’s esophagus with no dysplasia, indefinite for, or low-grade dysplasia. Am J Gastroenterol. 2015;110:943.

    Article  PubMed  Google Scholar 

  8. Feuerstein JD, Castillo NE, Akbari M, et al. Systematic analysis and critical appraisal of the quality of the scientific evidence and conflicts of interest in practice guidelines (2005–2013) for Barrett’s esophagus. Dig Dis Sci. 2016;61:2812–2822.

    Article  PubMed  Google Scholar 

  9. HHS Guidelines for Ensuring and Maximizing the Quality, Objectivity and Integrity of Information Disseminated to the Public. 2002. Accessed August 7, 2016, at https://aspe.hhs.gov/report/hhs-guidelines-ensuring-and-maximizing-quality-objectivity-utility-and-integrity-information-disseminated-public.

Download references

Author information

Authors and Affiliations

  1. Centre for Technology Enabled Health Research, Coventry University, Coventry, CV1 5FB, UK

    Cathy Bennett

  2. University of Central Lancashire (UCLan) Medical School, Rm 127 Lindow Centre, West Lakes, Cumbria, CA24 3JY, UK

    Janusz Jankowski

  3. Division of Gastroenterology, McMaster University, 1280 Main St. W. HSC 3V3, Hamilton, ON, L8S 4K1, Canada

    Paul Moayyedi

Authors
  1. Cathy Bennett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janusz Jankowski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul Moayyedi
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

On behalf of the International BAD CAT and BOB CAT consortia

Corresponding author

Correspondence to Janusz Jankowski.

Ethics declarations

Conflict of interest

Cathy Bennett is coordinator of BOB CAT and BAD CAT and has received a consultancy fee; member of the data and safety monitoring committee for the BOSS clinical trial (scheduled vs. at need surveillance endoscopy in BE); Proprietor of Systematic Research Ltd., a consultancy company; and derives an income from this. Janusz Jankowski was consultant to AstraZeneca from 2002 to 2012 (maker of a proton pump inhibitor); Chief Investigator of the aspirin chemoprevention trial, AspECT; and Chief Investigator of the EAGLe genomics consortia. Paul Moayyedi has accepted speaker fees from Shire and Allergan that make drugs for irritable bowel syndrome and ulcerative colitis; his endowed Chair is funded in part by an unrestricted donation given to McMaster University by AstraZeneca Canada.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bennett, C., Jankowski, J., Moayyedi, P. et al. Response to Feuerstein J et al. “Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005–2013) for Barrett’s Esophagus”. doi:10.1007/s10620-016-4222-2. Dig Dis Sci 61, 3369–3371 (2016). https://doi.org/10.1007/s10620-016-4279-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-016-4279-y

Keywords

Search

Navigation